Literature DB >> 26481978

The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia.

Vanessa L Cropley1, Elizabeth Scarr2, Alex Fornito3, Paul Klauser3, Chad A Bousman4, Rodney Scott5, Murray J Cairns5, Paul A Tooney5, Christos Pantelis4, Brian Dean2.   

Abstract

Previous research has demonstrated that individuals with schizophrenia who are homozygous at the c.267C>A single nucleotide polymorphism (rs2067477) within the cholinergic muscarinic M1 receptor (CHRM1) perform less well on the Wisconsin Card Sorting Test (WCST) than those who are heterozygous. This study sought to determine whether variation in the rs2067477 genotype was associated with differential changes in brain structure. Data from 227 patients with established schizophrenia or schizoaffective disorder were obtained from the Australian Schizophrenia Research Bank. Whole-brain voxel-based morphometry was performed to compare regional grey matter volume (GMV) between the 267C/C (N=191) and 267C/A (N=36) groups. Secondary analyses tested for an effect of genotype on cognition (the WCST was not available). Individuals who were homozygous (267C/C) demonstrated significantly reduced GMV in the right precentral gyrus compared to those who were heterozygous (267C/A). These preliminary results suggest that the rs2067477 genotype is associated with brain structure in the right precentral gyrus in individuals with schizophrenia/schizoaffective disorder. Future studies are required to replicate these results and directly link the volumetric reductions with specific cognitive processes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Imaging; Muscarinic M1 receptor (CHRM1); Schizoaffective disorder; Schizophrenia; Set-shifting; Single nucleotide polymorphism; Voxel-based morphometry

Mesh:

Substances:

Year:  2015        PMID: 26481978     DOI: 10.1016/j.pscychresns.2015.09.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

Review 1.  Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.

Authors:  Samantha E Yohn; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2017-09-09       Impact factor: 5.250

2.  A Novel Genotyping Method for Detection of the Muscarinic Receptor M1 Gene rs2067477 Polymorphism and Its Genotype/Allele Frequencies in a Turkish Population.

Authors:  Fezile Özdemir; Yağmur Kır; Kenan Can Tok; Bora Baskak; Halit Sinan Süzen
Journal:  Turk J Pharm Sci       Date:  2020-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.